Gaucher Disease is an inherited disorder resulting from a deficiency of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in cells and presenting with a range of symptoms, such as enlarged liver and spleen, skeletal abnormalities, and neurological complications. Treatment options include enzyme replacement therapy and substrate reduction therapy, aiming to alleviate symptoms and improve quality of life.